Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 15 | 2023 | 79 | 5.970 |
Why?
|
| Pseudomonas Infections | 8 | 2023 | 60 | 5.360 |
Why?
|
| ADP Ribose Transferases | 10 | 2022 | 15 | 2.830 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2022 | 29 | 2.370 |
Why?
|
| GTPase-Activating Proteins | 8 | 2022 | 9 | 2.360 |
Why?
|
| Wound Healing | 8 | 2023 | 168 | 2.300 |
Why?
|
| Surgical Wound Infection | 4 | 2022 | 98 | 1.840 |
Why?
|
| Wound Infection | 4 | 2022 | 13 | 1.650 |
Why?
|
| Apoptosis | 5 | 2022 | 259 | 1.600 |
Why?
|
| Animals | 22 | 2023 | 4637 | 1.400 |
Why?
|
| Bacillus subtilis | 7 | 2004 | 7 | 1.340 |
Why?
|
| Staphylococcal Infections | 3 | 2021 | 176 | 1.230 |
Why?
|
| Mitochondria | 3 | 2018 | 84 | 1.200 |
Why?
|
| Signal Transduction | 6 | 2022 | 491 | 1.170 |
Why?
|
| Neutrophils | 3 | 2022 | 118 | 1.080 |
Why?
|
| Bacterial Toxins | 4 | 2018 | 21 | 1.060 |
Why?
|
| Bacterial Proteins | 7 | 2007 | 76 | 1.060 |
Why?
|
| Cytokinesis | 3 | 2011 | 4 | 0.990 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2022 | 16 | 0.950 |
Why?
|
| Mice | 9 | 2022 | 1628 | 0.920 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2023 | 1 | 0.880 |
Why?
|
| HeLa Cells | 8 | 2021 | 52 | 0.880 |
Why?
|
| Melanoma | 2 | 2021 | 52 | 0.870 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 12 | 0.860 |
Why?
|
| Focal Adhesions | 2 | 2015 | 9 | 0.840 |
Why?
|
| Cell-Derived Microparticles | 1 | 2022 | 7 | 0.820 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2022 | 2 | 0.820 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 24 | 0.820 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2022 | 18 | 0.810 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2004 | 9 | 0.790 |
Why?
|
| Immunologic Factors | 1 | 2022 | 39 | 0.780 |
Why?
|
| Interleukin-10 | 1 | 2021 | 36 | 0.780 |
Why?
|
| Proto-Oncogene Proteins c-crk | 4 | 2015 | 4 | 0.770 |
Why?
|
| Transcription Factors | 5 | 2004 | 166 | 0.740 |
Why?
|
| Cytotoxins | 2 | 2023 | 5 | 0.730 |
Why?
|
| Type III Secretion Systems | 2 | 2022 | 2 | 0.730 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 180 | 0.730 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 140 | 0.710 |
Why?
|
| Cell Proliferation | 3 | 2017 | 206 | 0.710 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 28 | 0.670 |
Why?
|
| Diabetes Complications | 2 | 2022 | 64 | 0.650 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 215 | 0.640 |
Why?
|
| Spores, Bacterial | 5 | 2004 | 5 | 0.630 |
Why?
|
| Macrophages | 2 | 2021 | 128 | 0.620 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 11 | 0.590 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 78 | 0.570 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 86 | 0.560 |
Why?
|
| Low-Level Light Therapy | 3 | 2021 | 6 | 0.530 |
Why?
|
| Oxygen | 1 | 2016 | 86 | 0.530 |
Why?
|
| Diabetic Foot | 1 | 2015 | 4 | 0.520 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 21 | 0.520 |
Why?
|
| Anoikis | 1 | 2015 | 1 | 0.520 |
Why?
|
| Cell Survival | 2 | 2015 | 165 | 0.510 |
Why?
|
| Glucose | 4 | 2022 | 60 | 0.510 |
Why?
|
| Cartilage | 2 | 2014 | 154 | 0.510 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 57 | 0.490 |
Why?
|
| Insulin | 1 | 2015 | 92 | 0.480 |
Why?
|
| Blood Glucose | 1 | 2015 | 112 | 0.480 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 20 | 0.470 |
Why?
|
| Humans | 19 | 2023 | 29811 | 0.470 |
Why?
|
| Bacterial Secretion Systems | 1 | 2013 | 2 | 0.440 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 263 | 0.430 |
Why?
|
| Models, Animal | 2 | 2023 | 128 | 0.420 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 78 | 0.420 |
Why?
|
| Bacterial Infections | 1 | 2013 | 66 | 0.420 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 252 | 0.420 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 63 | 0.420 |
Why?
|
| Immunity, Innate | 1 | 2013 | 90 | 0.410 |
Why?
|
| Exotoxins | 2 | 2022 | 14 | 0.400 |
Why?
|
| Ethanol | 1 | 2013 | 134 | 0.390 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 224 | 0.380 |
Why?
|
| Cell Movement | 1 | 2011 | 104 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 435 | 0.360 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2021 | 124 | 0.360 |
Why?
|
| Virulence | 2 | 2023 | 15 | 0.350 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 164 | 0.350 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 744 | 0.330 |
Why?
|
| Mammals | 1 | 2008 | 26 | 0.320 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 401 | 0.300 |
Why?
|
| Mice, Knockout | 2 | 2022 | 309 | 0.300 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2018 | 4 | 0.290 |
Why?
|
| Caspase 9 | 2 | 2018 | 12 | 0.290 |
Why?
|
| Time-Lapse Imaging | 2 | 2018 | 8 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 463 | 0.280 |
Why?
|
| Phosphorylation | 3 | 2022 | 159 | 0.270 |
Why?
|
| Time Factors | 3 | 2018 | 1641 | 0.250 |
Why?
|
| Syntaxin 1 | 3 | 2011 | 3 | 0.250 |
Why?
|
| Cytochromes c | 2 | 2018 | 15 | 0.240 |
Why?
|
| Staphylococcus aureus | 2 | 2021 | 85 | 0.230 |
Why?
|
| Virulence Factors | 1 | 2023 | 10 | 0.220 |
Why?
|
| Blotting, Western | 2 | 2015 | 175 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 75 | 0.210 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 12 | 0.210 |
Why?
|
| Gene Amplification | 1 | 2002 | 23 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2015 | 12 | 0.210 |
Why?
|
| Mutation | 3 | 2015 | 397 | 0.210 |
Why?
|
| Biology | 1 | 2022 | 7 | 0.210 |
Why?
|
| Chemokine CCL3 | 1 | 2022 | 12 | 0.210 |
Why?
|
| Inflammasomes | 1 | 2022 | 15 | 0.200 |
Why?
|
| Operon | 1 | 2002 | 2 | 0.200 |
Why?
|
| Drug Evaluation | 1 | 2022 | 56 | 0.200 |
Why?
|
| Plasmids | 2 | 2002 | 44 | 0.200 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2021 | 11 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 81 | 0.200 |
Why?
|
| Chemokines | 1 | 2021 | 29 | 0.200 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2021 | 3 | 0.190 |
Why?
|
| Male | 7 | 2022 | 15850 | 0.190 |
Why?
|
| Skin | 3 | 2020 | 118 | 0.190 |
Why?
|
| Inflammation | 1 | 2023 | 347 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 403 | 0.180 |
Why?
|
| Rats | 5 | 2021 | 876 | 0.180 |
Why?
|
| Paxillin | 2 | 2011 | 2 | 0.180 |
Why?
|
| Ischemia | 1 | 2020 | 27 | 0.180 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 40 | 0.170 |
Why?
|
| Epithelial Cells | 4 | 2007 | 88 | 0.170 |
Why?
|
| Rats, Wistar | 4 | 2021 | 45 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2020 | 74 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 3 | 0.160 |
Why?
|
| Protein Domains | 1 | 2018 | 10 | 0.160 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 29 | 0.160 |
Why?
|
| Caspase 3 | 1 | 2018 | 30 | 0.160 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 16 | 0.160 |
Why?
|
| Cytosol | 1 | 2018 | 63 | 0.160 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 47 | 0.160 |
Why?
|
| Culture Media, Conditioned | 1 | 2018 | 31 | 0.160 |
Why?
|
| Vancomycin | 1 | 2018 | 58 | 0.160 |
Why?
|
| Photosensitizing Agents | 1 | 2018 | 5 | 0.160 |
Why?
|
| Curcumin | 1 | 2018 | 6 | 0.160 |
Why?
|
| Gene Library | 1 | 1997 | 8 | 0.150 |
Why?
|
| Mutagenesis | 1 | 1997 | 12 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 13 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 18 | 0.150 |
Why?
|
| Oncogenes | 1 | 2016 | 13 | 0.140 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2016 | 12 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2015 | 1 | 0.130 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 4 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2015 | 4 | 0.130 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 14 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 32 | 0.130 |
Why?
|
| Biofilms | 1 | 2015 | 15 | 0.130 |
Why?
|
| Streptozocin | 1 | 2015 | 6 | 0.130 |
Why?
|
| Microscopy, Video | 1 | 2015 | 5 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2015 | 112 | 0.130 |
Why?
|
| Integrins | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2015 | 45 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 232 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2015 | 177 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2020 | 3561 | 0.120 |
Why?
|
| Sterilization | 1 | 2014 | 10 | 0.120 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 273 | 0.120 |
Why?
|
| Lac Operon | 2 | 2003 | 2 | 0.120 |
Why?
|
| Artificial Gene Fusion | 2 | 2003 | 2 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 2 | 2003 | 3 | 0.120 |
Why?
|
| beta-Galactosidase | 2 | 2003 | 8 | 0.120 |
Why?
|
| Genes, Bacterial | 2 | 2003 | 6 | 0.120 |
Why?
|
| Protein Kinases | 2 | 2003 | 15 | 0.110 |
Why?
|
| Genes, Reporter | 2 | 2003 | 29 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 52 | 0.110 |
Why?
|
| Chlorhexidine | 1 | 2014 | 61 | 0.110 |
Why?
|
| Adherens Junctions | 1 | 2013 | 4 | 0.110 |
Why?
|
| Colony Count, Microbial | 1 | 2013 | 23 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2013 | 28 | 0.110 |
Why?
|
| Sigma Factor | 2 | 2003 | 2 | 0.110 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2003 | 3 | 0.110 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 55 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 107 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2013 | 94 | 0.100 |
Why?
|
| Chondrocytes | 1 | 2014 | 203 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 355 | 0.100 |
Why?
|
| Biomarkers | 1 | 2015 | 704 | 0.100 |
Why?
|
| Cell Line | 3 | 2007 | 299 | 0.100 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 7 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 201 | 0.100 |
Why?
|
| Integrin beta1 | 1 | 2011 | 9 | 0.100 |
Why?
|
| Cell Division | 1 | 2011 | 112 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 76 | 0.090 |
Why?
|
| Kinetics | 1 | 2011 | 230 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2011 | 202 | 0.090 |
Why?
|
| Transfection | 2 | 2007 | 130 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2002 | 49 | 0.090 |
Why?
|
| Actins | 2 | 2007 | 45 | 0.090 |
Why?
|
| Cytoskeleton | 2 | 2007 | 51 | 0.090 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 17 | 0.080 |
Why?
|
| Protein Transport | 1 | 2008 | 39 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2008 | 52 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 63 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 379 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 34 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 31 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 7 | 0.070 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 4 | 0.070 |
Why?
|
| ras Proteins | 1 | 2007 | 11 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2007 | 12 | 0.070 |
Why?
|
| Allografts | 2 | 2020 | 180 | 0.070 |
Why?
|
| Female | 3 | 2020 | 16410 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2004 | 38 | 0.060 |
Why?
|
| Morpholines | 1 | 2003 | 15 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 25 | 0.060 |
Why?
|
| Glutamine | 1 | 2003 | 9 | 0.060 |
Why?
|
| Culture Media | 1 | 2003 | 36 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 149 | 0.060 |
Why?
|
| Rec A Recombinases | 1 | 2002 | 1 | 0.050 |
Why?
|
| Taq Polymerase | 1 | 2002 | 2 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2002 | 6 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2002 | 9 | 0.050 |
Why?
|
| Chimera | 1 | 2002 | 5 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2002 | 61 | 0.050 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2002 | 1 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2002 | 30 | 0.050 |
Why?
|
| Base Sequence | 1 | 2002 | 133 | 0.050 |
Why?
|
| Mast Cells | 1 | 2021 | 25 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 245 | 0.050 |
Why?
|
| Stem Cells | 1 | 2021 | 49 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 46 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 6 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 53 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 143 | 0.040 |
Why?
|
| Lasers | 1 | 2018 | 16 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 58 | 0.040 |
Why?
|
| Subtilisins | 1 | 1997 | 1 | 0.040 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 1 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 33 | 0.040 |
Why?
|
| Gene Frequency | 1 | 1997 | 72 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 1997 | 57 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 73 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2016 | 19 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 266 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 225 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 158 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 174 | 0.030 |
Why?
|
| Femur | 1 | 2014 | 393 | 0.020 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 534 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 8741 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 42 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 41 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 30 | 0.010 |
Why?
|